Q

uniQure NV

D
QURE
USD
-0.1
(-1.7391%)
Market Closed
16,852.00
Volume
-4.23
EPS
-
Div Yield
-0.954392
P/E
275,141,547.35
Market Cap
Today
-1.7391%
1 Week
2.170%
1 Month
-13.872%
6 Months
9.922%
12 Months
-25.707%
Year To Date
-16.605%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
S
SNDX
0.61
(3.387%)
USD
G
GTHX
0.01
(0.1399%)
USD
C
CRSP
-0.11
(-0.2219%)
USD
E
EDIT
0.05
(1.292%)
USD
S
SGMO
0.0617
(7.3584%)
USD
B
BLUE
-0.0046
(-0.9287%)
USD
A
ALLO
0.025
(0.8681%)
USD
A
ABEO
0.36
(6.6055%)
USD

Title:
uniQure NV

Sector:
Healthcare
Industry:
Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Do you need help or have a question?
Contact Us